Bigfoot Biomedical, Inc., a diabetes company using artificial intelligence to develop solutions for optimizing the dosing and delivery of insulin, announces a new agreement with Eli Lilly and Company. The partnership will allow the integration of Lilly’s insulin products into Bigfoot’s systems currently in development. (January 7, 2019)
Decentralization of the world's electrical power generation continues with the introduction of demand response, distributed generation, and microgrid technologies. This Patent Forecast evaluates the fundamental payment and settlement state of the art of clearing and processing energy payment transactions.
View Patent Forecast®
Top Corporations
News and Insights
Data Visualization
Decentralization of the world's electrical power generation continues with the introduction of demand response, distributed generation, and microgrid technologies. This Patent Forecast evaluates the fundamental payment and settlement state of the art of clearing and processing energy payment transactions.